Combined dipyridamole and aspirin pellet formulation for improved oral drug delivery. Part 1: Development pharmaceutics

Journal of Microencapsulation

Volumn 13, Issue 4, 1996, Pages 385-394

  Deasy, P B ^a   Murtagh, P W ^a  

^a TRINITY COLLEGE DUBLIN   (Ireland)

Author keywords

Aspirin; Dipyridamole; In vitro evaluation; Pellets

Indexed keywords

ACETYLSALICYLIC ACID; DIPYRIDAMOLE; HYDROXYPROPYLMETHYLCELLULOSE ACETATE SUCCINATE; HYDROXYPROPYLMETHYLCELLULOSE PHTHALATE;

ARTICLE; DIFFERENTIAL SCANNING CALORIMETRY; DRUG SOLUBILITY; ENTERIC COATED TABLET; INFRARED SPECTROSCOPY; PH; SUSTAINED RELEASE PREPARATION; X RAY DIFFRACTION;

EID: 0030015978     PISSN: 02652048     EISSN: None     Source Type: Journal    
DOI: 10.3109/02652049609026025     Document Type: Article

References (13)

1. BETEN, D. B., GELBCKE, M., DIALLO, B., and MOES, A. J., 1992, Interaction between dipyridamole and Eudragit S. International Journal of Pharmaceutics, 88, 31-37.
2. BETEN, D. B., and MOES, A. J., 1994, Controlled-release coevaporates of dipyridamole prepared with acrylic polymers. International Journal of Pharmaceutics, 103, 243-251.
3. DEASY, P. B., 1984, Microencapsulation and Related Drug Processes (New York: Dekker), pp. 145-153.
4. FASSIO, G., ALBIZZATI, M. G., BASSI, S., and FRATTOLA, L., 1979, An investigation of the effect on platelet function of acetylsalicylic acid, dipyridamole and the two drugs in combination in patients with transient attacks of ischaemia. Journal of International Medical Research, 7, 492-501.
5. HASEGAWA, A., KAWAMURA, R., NAKAGAWA, H., AND SUGIMOTO, I., 1986, Application of solid dispersions with enteric coating agents to overcome some pharmaceutical problems. Chemical and Pharmaceutical Bulletin, 34, 2183-2190.
6. LEHMANN, C. R., LOCHE, K., SHAFLER, P. J., and PIERSON, W. P., 1984, Persantin bioavailability problems. Clinical Pharmacy, 3, 14-15.
7. MELLINGER, T. J., and BOHORFOUSH, J. G., 1965, Pathways and tissue distribution of dipyridamole (Persantin). Archives of International Pharmacodynamics, 156, 380-388.
8. NIELSEN-KUDSK, F., and PEDERSEN, A. K., 1979, Pharmacokinetics of dipyridamole. Acta Pharmacology and Toxicology, 44, 391-399.
9. RAJAH S. M., PENNY, A. F., COW, M. J., PEPPER, M. D., and WATSON, D. A., 1979, The interaction of varying doses of dipyridamole and acetylsalicylic acid on the inhibition of platelet functions and their effect on the bleeding time. British Journal of Clinical Pharmacology, 8, 483-489.
10. SEGALL, G. M., and DAVIS, M. J., 1988, Variability of serum drug level following single oral dose of dipyridamole. Journal of Nuclear Medicine, 29, 1662-1667.
11. TERHAAG, B., DONATH, F., LE PETIT, G., and FELLER, K., 1986, The absolute and relative bioavailability of dipyridamole from different preparations and the in vitro-in vivo comparison. International Journal of Clinical Pharmacology, Therapy and Toxicology, 24, 298-302.
12. THIESSEN, J. J., 1982, Aspirin:plasma concentration and effects. Thrombosis Research, (Supplement) IV, 163-170.
13. WILLIAMS, C., MAYER, P. R., and KILDSIG, D. O., 1983, Dissolution profiles of two tablet formulations of dipyridamole and their bioavailability. International Journal of Pharmaceutical Technology and Product Manufacture, 4, 74-76.